Yan Lü

4.9k total citations
116 papers, 3.5k citations indexed

About

Yan Lü is a scholar working on Molecular Biology, Epidemiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Yan Lü has authored 116 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 30 papers in Epidemiology and 20 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Yan Lü's work include Liver Disease Diagnosis and Treatment (21 papers), Metabolism, Diabetes, and Cancer (9 papers) and Adipose Tissue and Metabolism (9 papers). Yan Lü is often cited by papers focused on Liver Disease Diagnosis and Treatment (21 papers), Metabolism, Diabetes, and Cancer (9 papers) and Adipose Tissue and Metabolism (9 papers). Yan Lü collaborates with scholars based in China, United States and Italy. Yan Lü's co-authors include Huijie Zhang, Eduardo Slatopolsky, Xuelian Xiong, Xin Gao, Adriana Dusso, Min Li, Xiaopeng Zhu, Xi Xu, Mark D. Markel and Brian J. Cole and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Yan Lü

109 papers receiving 3.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yan Lü China 34 1.3k 920 632 414 408 116 3.5k
Assaad A. Eid Lebanon 34 1.4k 1.1× 513 0.6× 638 1.0× 431 1.0× 297 0.7× 131 3.7k
Stefano Menini Italy 41 1.3k 1.0× 581 0.6× 889 1.4× 472 1.1× 292 0.7× 72 4.0k
Mingxiang Zhang China 34 1.8k 1.4× 906 1.0× 1.1k 1.8× 444 1.1× 511 1.3× 120 4.3k
Qiaobing Huang China 37 1.8k 1.4× 759 0.8× 663 1.0× 332 0.8× 398 1.0× 142 4.1k
Satoshi Ugi Japan 35 1.9k 1.4× 642 0.7× 939 1.5× 504 1.2× 244 0.6× 110 3.5k
Akifumi Kushiyama Japan 29 1.2k 0.9× 609 0.7× 486 0.8× 452 1.1× 139 0.3× 98 2.6k
Hyun Jin Kim South Korea 29 1.3k 1.0× 715 0.8× 757 1.2× 385 0.9× 265 0.6× 166 3.3k
Allison B. Reiss United States 38 1.6k 1.3× 535 0.6× 760 1.2× 1.2k 2.8× 319 0.8× 118 4.8k
Gabriele G. Schiattarella Italy 33 2.1k 1.6× 980 1.1× 816 1.3× 605 1.5× 266 0.7× 108 4.9k
Kai Sun China 42 1.8k 1.4× 484 0.5× 408 0.6× 625 1.5× 538 1.3× 240 5.3k

Countries citing papers authored by Yan Lü

Since Specialization
Citations

This map shows the geographic impact of Yan Lü's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Lü with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Lü more than expected).

Fields of papers citing papers by Yan Lü

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yan Lü. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Lü. The network helps show where Yan Lü may publish in the future.

Co-authorship network of co-authors of Yan Lü

This figure shows the co-authorship network connecting the top 25 collaborators of Yan Lü. A scholar is included among the top collaborators of Yan Lü based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yan Lü. Yan Lü is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Zaitang, Yan Lü, Qi Li, & Yihe Huang. (2025). Dynamics of fractional stochastic diffusive SIRS epidemic model with Lévy noise. Chaos Solitons & Fractals. 200. 116886–116886.
2.
Sun, Lu, Xiaoyan Li, Feixiang Xu, et al.. (2025). A critical role of N4-acetylation of cytidine in mRNA by NAT10 in T cell expansion and antiviral immunity. Nature Immunology. 26(4). 619–634. 6 indexed citations
3.
Lu, Jie, Yuejun Liu, Ni Zhang, et al.. (2024). Improvement of MASLD and MASH by suppression of hepatic N-acetyltransferase 10. Molecular Metabolism. 89. 102030–102030. 7 indexed citations
4.
Ning, Zhilin, Ke Huang, Yuan Yuan, et al.. (2024). Analysis of sex-biased gene expression in a Eurasian admixed population. Briefings in Bioinformatics. 25(5). 2 indexed citations
5.
Lü, Yan, et al.. (2024). Acupuncture modulates the AMPK/PGC-1 signaling pathway to facilitate mitochondrial biogenesis and neural recovery in ischemic stroke rats. Frontiers in Molecular Neuroscience. 17. 1388759–1388759. 16 indexed citations
6.
Lü, Yan, Yueqi Zhang, Yuhan Zheng, et al.. (2024). Programmed Intermittent Epidural Bolus vs Manual Epidural Bolus for Labor Analgesia Initiation: A Randomized Non-Inferiority Trial. Drug Design Development and Therapy. Volume 18. 5063–5072. 1 indexed citations
9.
10.
Yang, Shu, Jiaqing Xiang, Guangyan Yang, et al.. (2022). KLF10 promotes nonalcoholic steatohepatitis progression through transcriptional activation of zDHHC7. EMBO Reports. 23(6). e54229–e54229. 24 indexed citations
11.
Yang, Shu, Guangyan Yang, Han Wu, et al.. (2021). MicroRNA-193b impairs muscle growth in mouse models of type 2 diabetes by targeting the PDK1/Akt signalling pathway. Diabetologia. 65(3). 563–581. 15 indexed citations
12.
Li, Yanning, Gehua Wen, Xinghua Ren, et al.. (2021). Long‐term ketamine administration induces bladder damage and upregulates autophagy‐associated proteins in bladder smooth muscle tissue. Environmental Toxicology. 36(12). 2521–2529. 6 indexed citations
13.
Wang, Shuyi, Jun Tao, Huaguo Chen, et al.. (2021). Ablation of Akt2 and AMPKα2 rescues high fat diet-induced obesity and hepatic steatosis through Parkin-mediated mitophagy. Acta Pharmaceutica Sinica B. 11(11). 3508–3526. 36 indexed citations
14.
Wu, Ling, Yang Jiao, Yao Li, et al.. (2021). Hepatic Gadd45β promotes hyperglycemia and glucose intolerance through DNA demethylation of PGC-1α. The Journal of Experimental Medicine. 218(5). 11 indexed citations
15.
Liu, Caizhi, Bing Zhou, Meiyao Meng, et al.. (2021). FOXA3 induction under endoplasmic reticulum stress contributes to non-alcoholic fatty liver disease. Journal of Hepatology. 75(1). 150–162. 69 indexed citations
16.
Qi, Lu‐Nan, Bang‐De Xiang, Feixiang Wu, et al.. (2018). Circulating Tumor Cells Undergoing EMT Provide a Metric for Diagnosis and Prognosis of Patients with Hepatocellular Carcinoma. Cancer Research. 78(16). 4731–4744. 226 indexed citations
17.
Wu, Ling, Yan Lü, Yang Jiao, et al.. (2016). Paternal Psychological Stress Reprograms Hepatic Gluconeogenesis in Offspring. Cell Metabolism. 23(4). 735–743. 112 indexed citations
18.
Liu, Xing, J. Leon Zhao, Qi Liu, et al.. (2016). MicroRNA-124 promotes hepatic triglyceride accumulation through targeting tribbles homolog 3. Scientific Reports. 6(1). 37170–37170. 23 indexed citations
19.
Shi, Guojun, Zhijian Zhang, Dechun Feng, et al.. (2010). Selection of reference genes for quantitative real-time reverse transcription-polymerase chain reaction in concanavalin A-induced hepatitis model. Analytical Biochemistry. 401(1). 81–90. 13 indexed citations
20.
Dusso, Adriana, Yan Lü, Jane Finch, et al.. (2001). p21WAF1 and transforming growth factor-α mediate dietary phosphate regulation of parathyroid cell growth. Kidney International. 59(3). 855–865. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026